Granahan Investment Management LLC Has $14.36 Million Stock Holdings in Enovix Corporation $ENVX

Granahan Investment Management LLC raised its stake in Enovix Corporation (NASDAQ:ENVX) by 12.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,964,565 shares of the company’s stock after acquiring an additional 214,916 shares during the period. Granahan Investment Management LLC’s holdings in Enovix were worth $14,361,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ENVX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Enovix by 5.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company’s stock valued at $722,000 after acquiring an additional 4,780 shares in the last quarter. NewEdge Advisors LLC raised its holdings in Enovix by 10.4% in the 1st quarter. NewEdge Advisors LLC now owns 26,257 shares of the company’s stock valued at $193,000 after acquiring an additional 2,481 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in Enovix by 65.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock valued at $8,351,000 after acquiring an additional 449,934 shares in the last quarter. Caxton Associates LLP acquired a new position in Enovix in the 1st quarter valued at $190,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Enovix by 18.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company’s stock valued at $2,628,000 after acquiring an additional 55,676 shares in the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.

Enovix Trading Down 6.4%

Shares of ENVX stock opened at $6.63 on Wednesday. The stock’s fifty day simple moving average is $6.74 and its 200 day simple moving average is $6.74. Enovix Corporation has a twelve month low of $4.61 and a twelve month high of $16.49. The firm has a market capitalization of $1.45 billion, a P/E ratio of -7.99 and a beta of 2.27. The company has a quick ratio of 10.65, a current ratio of 10.97 and a debt-to-equity ratio of 2.14.

Enovix (NASDAQ:ENVX) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The company had revenue of $7.60 million during the quarter, compared to analysts’ expectations of $6.95 million. During the same quarter in the prior year, the firm posted ($0.15) earnings per share. The business’s quarterly revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, sell-side analysts predict that Enovix Corporation will post -0.79 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ENVX. Oppenheimer dropped their price objective on Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a report on Thursday, May 14th. Canaccord Genuity Group dropped their price objective on Enovix from $21.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Benchmark dropped their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Wells Fargo & Company set a $6.00 price objective on Enovix in a report on Thursday, March 12th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research note on Friday, April 10th. Seven investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $12.64.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.